FDA
-
-
-
-
-
-
-
Dexcom receives FDA clearance for basal insulin dosing optimizer
-
-
-
-
-
-
-
Dexcom Spotlights Upcoming Feature Launches, Improved Health Outcomes and Cost-Effectiveness With Dexcom Glucose Biosensing at EASD 2025
-
-
-
-
-
-
-
DexCom (DXCM) PT Lowered to $88 at Bernstein SocGen Group
-
-
-
-
-
-
-
DexCom (DXCM) G7 15 Day Receives FDA Clearance
-
-
-
-
-
-
-
Dexcom Launches the First Generative AI Platform in Glucose Biosensing
-
-
-
-
-
-
-
Oppenheimer Reiterates Outperform Rating on DexCom (DXCM)
-
-
-
-
-
-
-
Dexcom Showcases Leadership in AID and Power of Dexcom CGM in Type 2 Diabetes With New Data at ATTD
-
322,748 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

